Tintner, Ron

Publications

Sort by

Co-Author Network

selected publications

Reliability of a new scale for essential tremor. Movement disorders : official journal of the Movement Disorder Society. 2012 Academic Article GET IT
Times cited: 131
Report from a U.S. conference on essential tremor. Movement disorders : official journal of the Movement Disorder Society. 2006 Review GET IT
Times cited: 44
Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain : a journal of neurology. 2006 Academic Article GET IT
Times cited: 144
Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial. Neurology. 2005 Academic Article GET IT
Times cited: 72
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2005 Academic Article GET IT
Times cited: 240
Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease. 2005 GET IT
Times cited: 53
Striatal deformities of the hand and foot in Parkinson's disease. The Lancet. Neurology. 2005 Review GET IT
Times cited: 101
Dopamine agonists in Parkinson's disease. Expert opinion on investigational drugs. 2003 Review GET IT
Times cited: 25
Benefits and risks of pharmacological treatments for essential tremor. Drug safety. 2003 Review GET IT
Times cited: 92
Treatment options for Parkinson's disease. Current opinion in neurology. 2002 Review GET IT
Times cited: 43
Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. 2002 GET IT
Times cited: 114
Tetrabenazine treatment for Huntington's disease-associated chorea. Clinical neuropharmacology. 2002 Academic Article GET IT
Times cited: 70
Botulinum toxin for the treatment of cervical dystonia. Expert opinion on pharmacotherapy. 2001 Review GET IT
Times cited: 17
Dystonia and parkinsonism. Parkinsonism & related disorders. 2001 Review GET IT
Times cited: 108
Focal dystonia: the role of botulinum toxin. Current neurology and neuroscience reports. 2001 Review GET IT
Times cited: 17
Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome. 1998 GET IT
Times cited: 36
Cognitive deficits in asymptomatic first-degree relatives of Alzheimer's disease patients. Journal of clinical and experimental neuropsychology. 1994 Academic Article GET IT
Times cited: 17
Brain blood flow in the dementias: SPECT with histopathologic correlation. Radiology. 1993 Academic Article GET IT
Times cited: 57
Xenon-133 SPECT-determined regional cerebral blood flow in Alzheimer's disease: what is typical?. The Journal of neuropsychiatry and clinical neurosciences. 1993 Academic Article GET IT
Times cited: 10
Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science (New York, N.Y.). 1992 Academic Article GET IT
Times cited: 1330
Experiences with depression in a dementia clinic. The Journal of clinical psychiatry. 1991 Academic Article GET IT
Times cited: 27
Single photon tomography in Alzheimer's disease and the dementias. Seminars in nuclear medicine. 1990 Review GET IT
Times cited: 47
Evaluation of quantitative measures of upper extremity speed and coordination in healthy persons and in three patient populations. Archives of physical medicine and rehabilitation. 1990 Academic Article GET IT
Times cited: 10
The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography. Investigative radiology. 1989 Academic Article GET IT
Times cited: 41
Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications. 1986 GET IT
Times cited: 41
Corticotrophin increases cerebral polyamine content. Journal of neurochemistry. 1979 Academic Article GET IT
Times cited: 11
Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice. Hormones and behavior. 1978 Academic Article GET IT
Times cited: 82

more ...

less ...

Background

education and training

M.D., University of Florida College of Medicine 1980
M.S., University of Massachusetts 1975
B.A., B.S., University of Miami 1973

Contact

full name

Ron Tintner

VIVO Weill Cornell Medical College

Ron Tintner Clinical Associate Professor of Neurology

Publications

selected publications

Background

education and training

Contact

full name